Skip to search formSkip to main contentSkip to account menu

IDD-3

Known as: Allogeneic Melanoma Cell-Loaded Dendritic Cell Vaccine, Autologous Dendritic Cell-Allogeneic Melanoma Tumor Cell Lysate Vaccine 
A cell-based vaccine composed of autologous dendritic cells (DCs) pulsed with lysates from heat-treated allogeneic melanoma tumor cells. Upon… 
National Institutes of Health

Search for papers about IDD-3

Search papers